{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:02:21Z","timestamp":1789520541284,"version":"build-2803163510"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"35","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,16]]},"DOI":"10.1093\/eurheartj\/ehag727","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:27:46Z","timestamp":1787570866000},"page":"4853-4859","source":"Crossref","is-referenced-by-count":0,"title":["Focus on the many facets of cardio-oncology"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-411X","authenticated-orcid":false,"given":"Filippo","family":"Crea","sequence":"first","affiliation":[{"name":"Center of Excellence of Cardiovascular Sciences, Ospedale Isola Tiberina \u2013 Gemelli Isola , Rome ,","place":["Italy"]},{"name":"Catholic University of the Sacred Heart , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"2026091520023111200_ehag727-B1","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1093\/eurheartj\/ehag089","article-title":"Exercise training for cardiovascular prevention in patients with cancer","volume":"47","author":"Piepoli","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B2","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/eurheartj\/ehaf869","article-title":"Transient cardiomyopathy by tyrosine kinase inhibitor therapy: time to define a new syndrome in cardio-oncology?","volume":"47","author":"Lehmann","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B3","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/eurheartj\/ehaf100","article-title":"Cardio-oncology rehabilitation and exercise: evidence, priorities, and research standards from the ICOS-CORE working group","volume":"46","author":"Adams","year":"2025","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B4","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/eurheartj\/ehaf019","article-title":"The year in cardiovascular medicine 2024: the top 10 papers in cardio-oncology","volume":"46","author":"Herrmann","year":"2025","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B5","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1093\/eurheartj\/ehae556","article-title":"A focus on two rapidly expanding fields: cardio-oncology and genetics","volume":"45","author":"Crea","year":"2024","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/eurheartj\/ehae496","article-title":"Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score","volume":"46","author":"Rivero-Santana","year":"2025","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B7","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/eurheartj\/ehae397","article-title":"Innovative therapeutic targets in cardio-oncology and a Great Debate in heart failure","volume":"45","author":"Crea","year":"2024","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B8","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1093\/eurheartj\/ehag144","article-title":"Senescent obesity signature in breast cancer: a paradigm of reverse cardio-oncology","volume":"47","author":"Carbone","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B9","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1093\/eurheartj\/ehaf497","article-title":"Low-density lipoprotein cholesterol and cardiovascular risk in the absence of calcifications on computed tomography: the Western Denmark Heart Registry","volume":"46","author":"Andersen","year":"2025","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B10","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1093\/eurheartj\/ehaf274","article-title":"Residual cardiovascular risk beyond low-density lipoprotein cholesterol: inflammation, remnant cholesterol, and lipoprotein(a)","volume":"46","author":"Wulff","year":"2025","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B11","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1093\/eurheartj\/ehaf281","article-title":"Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events","volume":"46","author":"Markus","year":"2025","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B12","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1093\/eurheartj\/ehaf209","article-title":"Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study","volume":"46","author":"Kraaijenhof","year":"2025","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B13","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1093\/eurheartj\/ehaf830","article-title":"Cascade screening for high lipoprotein(a): the time has come","volume":"47","author":"Bittner","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B14","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1093\/eurheartj\/ehaf526","article-title":"Lipoprotein(a) and forms of dementia: an area of complexity","volume":"46","author":"Kronenberg","year":"2025","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B15","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1093\/eurheartj\/ehaf677","article-title":"Major cardiovascular events in first-degree relatives of individuals with elevated plasma lipoprotein(a): a registry-based cohort study","volume":"47","author":"Kindborg","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B16","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1093\/eurheartj\/ehaf444","article-title":"Hot topics in prevention: resistant hypertension, blood pressure variability, triglycerides, and apoB-containing lipoproteins","volume":"46","author":"Crea","year":"2025","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B17","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1093\/eurheartj\/ehaf422","article-title":"Ignorance is not bliss: the importance of lipoprotein(a) testing","volume":"46","author":"O\u2019Donoghue","year":"2025","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B18","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1093\/eurheartj\/ehaf472","article-title":"Cumulative exposure to atherogenic lipoprotein particles in young adults and subsequent incident atherosclerotic cardiovascular disease","volume":"46","author":"Zheutlin","year":"2025","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B19","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1093\/eurheartj\/ehag265","article-title":"Dyslipidaemias in cancer patients","volume":"47","author":"Nazir","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B20","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1093\/eurheartj\/ehag562","article-title":"Cardiovascular risk-prediction models in cancer survivors: a meta-analysis","volume":"47","author":"Kazemian","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B21","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1093\/eurheartj\/ehag394","article-title":"Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiaries","volume":"47","author":"Zaghlol","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B22","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1093\/eurheartj\/ehag448","article-title":"Understanding cardiovascular events in older CAR-T patients: beyond chronological age","volume":"47","author":"Mart\u00edn-Garc\u00eda","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B23","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1093\/eurheartj\/ehaf1060","article-title":"Anthracycline cardiotoxicity: role of metabolic vulnerability induced by cardiac pressure overload","volume":"47","author":"Gal\u00e1n-Arriola","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B24","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1093\/eurheartj\/ehag123","article-title":"Anthracycline-induced cardiotoxicity: why is the individual response so variable?","volume":"47","author":"van der Meer","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B25","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1093\/eurheartj\/ehag147","article-title":"Breast tumour-secreted ADAM10 mediates atrial fibrogenesis and fibrillation","volume":"47","author":"Xue","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B26","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1093\/eurheartj\/ehag185","article-title":"Breast cancer, fibrotic signalling, and development of atrial fibrillation","volume":"47","author":"Van Wagoner","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B27","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1093\/eurheartj\/ehag487","article-title":"Cardiac remodelling and dysfunction in cancer patients receiving cardiotoxic therapies: proteomic and metabolomic profiling","volume":"47","author":"Ky","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B28","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1093\/eurheartj\/ehag507","article-title":"Decoding cardiotoxicity through proteomics and metabolomics: cathepsin C and amino acids take centre stage","volume":"47","author":"Guerra","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B29","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1093\/eurheartj\/ehag314","article-title":"Cardiac implantable electronic devices and radiation therapy: long-term outcomes","volume":"47","author":"Tajstra","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B30","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1093\/eurheartj\/ehag371","article-title":"Immune checkpoint inhibitor myocarditis: a metagenomic investigation of infectious pathogens","volume":"47","author":"Lorca","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B31","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1093\/eurheartj\/ehag495","article-title":"Biomarkers in cancer thrombosis: from association to mechanism and integrated risk","volume":"47","author":"Xiao","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B32","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/eurheartj\/ehaf1002","article-title":"Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers","volume":"47","author":"Roy","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091520023111200_ehag727-B33","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1093\/eurheartj\/ehag496","article-title":"Biomarkers, association, and prediction in cancer-associated thrombosis and bleeding","volume":"47","author":"Roy","year":"2026","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/35\/4853\/71083166\/ehag727.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/35\/4853\/71083166\/ehag727.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:02:37Z","timestamp":1789516957000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/35\/4853\/8795242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":33,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2026,9,16]]},"published-print":{"date-parts":[[2026,9,16]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag727","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,14]]},"published":{"date-parts":[[2026,9,14]]}}}